286 related articles for article (PubMed ID: 2142000)
1. Platelet and erythrocyte membrane changes in Alzheimer's disease.
Hajimohammadreza I; Brammer MJ; Eagger S; Burns A; Levy R
Biochim Biophys Acta; 1990 Jun; 1025(2):208-14. PubMed ID: 2142000
[TBL] [Abstract][Full Text] [Related]
2. Membrane fluidity of platelets and erythrocytes in patients with Alzheimer's disease and the effect of small amounts of aluminium on platelet and erythrocyte membranes.
van Rensburg SJ; Carstens ME; Potocnik FC; Aucamp AK; Taljaard JJ; Koch KR
Neurochem Res; 1992 Aug; 17(8):825-9. PubMed ID: 1641066
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of internal membranes in platelets from patients with Alzheimer's disease.
Zubenko GS; Malinakova I; Chojnacki B
J Neuropathol Exp Neurol; 1987 Jul; 46(4):407-18. PubMed ID: 3598604
[TBL] [Abstract][Full Text] [Related]
4. Impact of gender on platelet membrane functions of Alzheimer's disease patients.
Vignini A; Giusti L; Raffaelli F; Giulietti A; Salvolini E; Luzzi S; Provinciali L; Mazzanti L; Nanetti L
Exp Gerontol; 2013 Mar; 48(3):319-25. PubMed ID: 23228953
[TBL] [Abstract][Full Text] [Related]
5. Platelet membrane fluidity and intraplatelet Ca2+ homeostasis are affected in uremia.
Walkowiak B; Koziołkiewicz W; Michalec L; Borkowska E; Cierniewski CS
Pol J Pharmacol; 1996; 48(3):299-302. PubMed ID: 9112666
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxidation and platelet membrane fluidity--implications for Alzheimer's disease?
van Rensburg SJ; Daniels WM; van Zyl J; Potocnik FC; van der Walt BJ; Taljaard JJ
Neuroreport; 1994 Nov; 5(17):2221-4. PubMed ID: 7881031
[TBL] [Abstract][Full Text] [Related]
7. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients.
Piletz JE; Sarasua M; Whitehouse P; Chotani M
Neurobiol Aging; 1991; 12(5):401-6. PubMed ID: 1770973
[TBL] [Abstract][Full Text] [Related]
8. Platelet and erythrocyte Mg2+, Ca2+, Na+, K+ and cell membrane adenosine triphosphatase activity in essential hypertension in blacks.
Touyz RM; Milne FJ; Reinach SG
J Hypertens; 1992 Jun; 10(6):571-8. PubMed ID: 1320078
[TBL] [Abstract][Full Text] [Related]
9. Membrane fluidity of non-activated and activated human blood platelets.
Feijge MA; Heemskerk JW; Hornstra G
Biochim Biophys Acta; 1990 Jun; 1025(2):173-8. PubMed ID: 2364076
[TBL] [Abstract][Full Text] [Related]
10. Molecular order and fluidity of the plasma membrane of human platelets from time-resolved fluorescence depolarization.
Mateo CR; Lillo MP; González-Rodríguez J; Acuña AU
Eur Biophys J; 1991; 20(1):41-52. PubMed ID: 1935812
[TBL] [Abstract][Full Text] [Related]
11. Platelet membrane abnormality in Alzheimer's disease.
Zubenko GS; Cohen BM; Boller F; Malinakova I; Keefe N; Chojnacki B
Ann Neurol; 1987 Aug; 22(2):237-44. PubMed ID: 3662454
[TBL] [Abstract][Full Text] [Related]
12. Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets.
Cutler L; Rodan G; Feinstein MB
Biochim Biophys Acta; 1978 Sep; 542(3):357-71. PubMed ID: 150866
[TBL] [Abstract][Full Text] [Related]
13. Altered platelet membrane dynamic properties in type 1 diabetes.
Mazzanti L; Rabini RA; Fumelli P; Martarelli D; Staffolani R; Salvolini E; Curatola G
Diabetes; 1997 Dec; 46(12):2069-74. PubMed ID: 9392498
[TBL] [Abstract][Full Text] [Related]
14. Temperature dependence of the molecular dynamics of platelet membranes in Alzheimer's disease.
Zubenko GS; Malinakova I; Cohen BM
Biol Psychiatry; 1987 Aug; 22(8):987-94. PubMed ID: 3607139
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum abnormality in Alzheimer's disease: selective alteration in platelet NADH-cytochrome c reductase activity.
Zubenko GS
J Geriatr Psychiatry Neurol; 1989; 2(1):3-10. PubMed ID: 2742732
[TBL] [Abstract][Full Text] [Related]
16. Platelet and erythrocyte membrane microviscosity in Lyon hypertensive rats.
Le Quan Sang KH; Kunes J; Zicha J; Vincent M; Sassard J; Devynck MA
Am J Hypertens; 1994 Mar; 7(3):276-81. PubMed ID: 8003280
[TBL] [Abstract][Full Text] [Related]
17. Detection of membrane fluidity in submitochondrial particles of platelets and erythrocyte membranes from Mexican patients with Alzheimer disease by intramolecular excimer formation of 1,3 dipyrenylpropane.
Ortiz GG; Pacheco-Moisés F; El Hafidi M; Jiménez-Delgado A; Macías-Islas MA; Rosales Corral SA; de la Rosa AC; Sánchez-González VJ; Arias-Merino ED; Velázquez-Brizuela IE
Dis Markers; 2008; 24(3):151-6. PubMed ID: 18334736
[TBL] [Abstract][Full Text] [Related]
18. Studies on the bivalent-cation-activated ATPase activities of highly purified human platelet surface and intracellular membranes.
Hack N; Croset M; Crawford N
Biochem J; 1986 Feb; 233(3):661-8. PubMed ID: 2939826
[TBL] [Abstract][Full Text] [Related]
19. Platelet membrane fluidity individuals at risk for Alzheimer's disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy.
Zubenko GS; Kopp U; Seto T; Firestone LL
Psychopharmacology (Berl); 1999 Jul; 145(2):175-80. PubMed ID: 10463318
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the platelet plasma membrane does not contain a (Ca2+ + Mg2+)-dependent ATPase.
Steiner B; Lüscher EF
Biochim Biophys Acta; 1985 Sep; 818(3):299-309. PubMed ID: 2994727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
